GW Pharmaceuticals Plc American Depositary Shares
GWPH
GWPH was delisted on the 4th of May, 2021.
191 hedge funds and large institutions have $2.43B invested in GW Pharmaceuticals Plc American Depositary Shares in 2018 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 69 increasing their positions, 46 reducing their positions, and 39 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 69 | Existing positions reduced: 46
6% less funds holding
Funds holding: 204 → 191 (-13)
20% less capital invested
Capital invested by funds: $3.03B → $2.43B (-$599M)
29% less call options, than puts
Call options by funds: $83.6M | Put options by funds: $118M
33% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 39
67% less funds holding in top 10
Funds holding in top 10: 6 → 2 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$93.7M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$26.9M |
| 3 |
Barclays
London,
United Kingdom
|
+$22M |
| 4 |
EMG
ETF Managers Group
Summit,
New Jersey
|
+$18.7M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$17.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Scopia Capital Management
New York
|
-$93M |
| 2 |
CCM
Consonance Capital Management
New York
|
-$50.6M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$41.4M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$39.9M |
| 5 |
Mirae Asset Global Investments
Seoul,
South Korea
|
-$28.6M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
226
CIBC Private Wealth Group
Atlanta,
Georgia
| – | +$251 | +2 | New |
|
GWPH Hedge Fund Activity: Q1 2018 in Review
191 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) for Q1 2018, worth a combined $2.43B — down 20% from $3.03B a quarter earlier.
Sellers outnumbered buyers: 39 funds closed out of GWPH and 26 opened new positions — a net loss of 13 holders — while 46 trimmed existing stakes and 69 added.
The largest buyer was Capital World Investors, adding an estimated $93.7M. The largest seller was Scopia Capital Management, cutting an estimated $93M.
- 191 institutional investors held GW Pharmaceuticals Plc American Depositary Shares (GWPH) as of Q1 2018, down from 204 in Q4 2017.
- Funds reported $2.43B of GW Pharmaceuticals Plc American Depositary Shares stock for Q1 2018, down 20% quarter-over-quarter.
- 26 funds opened new GW Pharmaceuticals Plc American Depositary Shares positions in Q1 2018 and 39 closed out, a net change of -13 holders.
- The largest GW Pharmaceuticals Plc American Depositary Shares buyer in Q1 2018 was Capital World Investors, an estimated $93.7M added.
- The largest GW Pharmaceuticals Plc American Depositary Shares seller in Q1 2018 was Scopia Capital Management, an estimated $93M sold.
Based on aggregated 13F filings for Q1 2018.